Will Neuralstem Phase II Results Pave The Road To A Stem Cell Cure For ALS … – Seeking Alpha (registration)
|
Will Neuralstem Phase II Results Pave The Road To A Stem Cell Cure For ALS …
Seeking Alpha (registration) Neuralstem will present top line Phase II data of stem–cell therapy in ALS, during late February – early March. Stem cells have been studied for decades as a potential cure for neurodegeneration, so far without successful outcomes. NSI-566 stem cells … Stocks to Track-Neuralstem, (CUR), Angie's List (ANGI), Molycorp (MCP), Amarin … Brean Capital Initiates Coverage on Neuralstem (CUR) |
